Search Results

240 results for dgse

June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge

Biotech surge alert! Discover three biotech stocks to buy as they catch up with the market in the rest of 2024.

Ready for Quick Gains? 7 Top Short-Squeeze Stocks to Watch Now

Each of the following seven heavily-shorted stocks may have what it takes to become one of the next big short squeeze stocks.

The Dividend Dominators: 3 Stocks That Will Make Your Portfolio Reign Supreme

Top dividend stocks across various sectors continue to reward investors, even as they face sales shortfalls and leadership changes.

7 Penny Biotech Stocks to Triple Your Investment

Biotech penny stocks offer the chance to triple your investments and require an appetite for risk in order to capture returns.

3 Sorry China Stocks to Sell in May While You Still Can

With rising interest rates and geopolitical tensions, now may be the time to reevaluate China stocks to sell for a more secure portfolio.

3 Cannabis Stocks to Buy Now: May 2024

These cannabis stocks to buy offer the best odds at capturing long-term upside from current rescheduling initiatives.

NKGN Stock Alert: The Alzheimer’s News That Has NKGen Biotech Soaring Today

NKGen Biotech stock is up with heavy trading of NKGN shares alongside approval for its Phase 2 clinical trial of its Alzheimer’s treatment.

GVP Stock Earnings: GSE Systems Beats EPS, Misses Revenue for Q1 2024

GVP stock results show that GSE Systems beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

What in the World Should You Do About Gold?

The gold bubble is a lingering field, so spread your wealth out between direct stocks and ETFs, and play it slow.

Weak Caterpillar Earnings Hurt Transport Stocks

Caterpillar NYSE:CAT earnings weigh on transport stocks, as DSGE stock rallies to a new high.

What’s Shiny and Dropping Like a Rock?

Diamonds may be a girl’s best friend, but they’re certainly not an investor’s. Don’t let these four stocks take you down with them.

How to Profit From the Euro Zone Crisis

A deepening crisis in the euro zone is unavoidable, so play it to your advantage. Here are three strategies to keep you safe from the…

Not Holding Gold Yet? Hurry Up!

Even as gold nears $1,800 an ounce again, there are good reasons to invest in the yellow metal now. Here’s why it may not be…

Diamonds Aren’t Forever. Sell Blue Nile Now

The Internet gem merchant is hardly sparkling these days. One reason for that: Buying a diamond online lacks the special experience of doing so at…

3 Stocks Under $12 Set to Double

Whether they’re undiscovered gems, damaged goods or in little-understood businesses, these under-$12 stocks have oodles of upside.

Analyst Upgrades: 3 Stocks Getting the Nod From Pros Last Week

Explore key insights on stocks with analyst upgrades and their impact on market trends amid economic shifts.

Should You Buy Sears Holding Corp (SHLD) Stock? 3 Pros, 3 Cons

Sears stock has recovered somewhat, but the company’s troubles remain. Is there a case for holding SHLD stock anyways?

3 Underappreciated Stocks That Could 10x in 10 Years

10x stocks are the holy grail of capital investing. So, here are three companies that have the potential to cross that line.

Top Russell 2000 Picks: 3 Small-Cap Stocks to Scoop Up This May

Some of the top Russell 2000 stocks to buy are those that few investors pay attention to but offer great potential nonetheless.

Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine

These biotech breakthrough stocks give investors a glimpse into medicine’s future — and massive moneymaking opportunities to boot.

3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire

Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion.

Greed Pays: 3 Stocks to Load Up on While Everyone Flees

These stocks to load up on have sold off on some negative headlines, but the long-term growth trajectory is intact.

7 Crypto Scams You Absolutely Need to Avoid

Why Is Bio-Path (BPTH) Stock Up 89% Today?

Bio-Path stock is up with heavy trading of BPTH shares today alongside positive news from its ongoing clinical trial of BP1002.

2 – 10 of 240 results